Here’s a podcast of my recent Guardian column, Why all pharmaceutical research should be made open access: One of the strongest arguments for public access in scholarly and scientific publication is the “public debt” argument: if the public pays you to do research, the research should belong to the public. That’s a good argument, but... <a href="https://craphound.com/news/2012/11/26/why-all-pharmaceutical-research-should-be-made-open-access-2/" class="more-link" title="Read Why all pharmaceutical research should be made open access">more <i class="fa fa-chevron-right"></i></a>

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.